MissionIR Articles

VistaGen Therapeutics, a biotech company focused on applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, reports that its human pluripotent stem cell-derived cardiomyocytes (heart cells) were used by a collaboration…

Stem cell technology has traditionally been associated with therapeutic regeneration, using these basic building blocks of life to generate new cells that can replace damaged cells. Potential therapeutic applications run the gamut from the replacement…

The strategy of VistaGen Therapeutics, a California based stem-cell technology company, is primed to drive rapid growth because of its unique structure. VistaGen is a developer of stem-cell based bioassay early-warning systems for determining possible…

The importance of the work being done at VistaGen Therapeutics, developers of stem-cell based bioassay early-warning systems for determining possible toxicity of drug candidates, can be seen in the clinical disasters occasionally experienced by major…

VistaGen Therapeutics, a biotechnology company with stem cell technology designed to improve the predictability of the drug development cycle and lower the cost of new drug R&D, just announced the signing of a strategic financing…

VistaGen Therapeutics is a California biotechnology company focused primarily on the use of its proprietary pluripotent stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. The core…

Why do pharmaceutical drugs cost so much? Because pharmaceutical companies waste so much money and time developing them. But these companies can be excused for wasting hundreds of millions of dollars and years of work…

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, has been scheduled to present key enhancements to LiverSafe 3D™, its human liver cell-based bioassay system designed…

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, just announced it will feature key developments involving CardioSafe 3D™, its pluripotent stem cell-based bioassay system for…

Today before the opening bell, VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, announced it has entered a new collaboration agreement with Celsis In Vitro…

When it comes to the pharmaceutical world, few things are more important than current and future relationships with other companies and organizations. For emerging companies, partnerships are often critical, helping to drive research and build…

If there is one thing that seems to define modern health care, it’s costs. Today, there are options that never had to be considered in the past, but options that come at a price. High-tech…

The advent of stem cell technology is proving to be one of the most foundational developments in the history of modern medicine. Like the stem cell itself, this rapidly developing technology is showing a remarkable…

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, earlier today announced significant advancements in its stem cell technology licensed from the University Health Network (UHN)…

A recent article by Ryan McBride in biotech industry newsletter FierceBiotech (http://dtg.fm/i12W) highlights a major transition that needs to occur in the pharmaceutical industry. The article points to a speech by Ken Kaitin, director of…

A recent article published by Seeking Alpha, titled “Supreme Court Decision Is Bullish For Stem Cell Companies,” reviews the recent high court decision that allows medical universities and science foundations to receive federal funding for…

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, excitedly reported today the successful completion of its final Phase 1 safety study of AV-101, a novel…

Today before the opening bell, VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, told investors that Shawn K. Singh, CEO of VistaGen, will be stepping…

California-based VistaGen Therapeutics, a biotechnology company applying proprietary human pluripotent stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, has been highly effective in pro-actively partnering with important academic and government research…

A lot of great things have been happening with VistaGen Therapeutics recently. VistaGen is a California-based biotechnology company actively applying its proprietary human pluripotent stem cell technology to launch a new era of drug rescue,…